Premaitha Health PLC (Formerly ViaLogy PLC) ("Premaitha" or the "Company"): First Day of Dealings on AIM

Premaitha Joins AIM and Looks to Deliver Diagnostic Test Product to Improve Prenatal Screening Globally


LONDON, UNITED KINGDOM--(Marketwired - Jul 4, 2014) - Premaitha Health PLC (LSE: NIPT)

Admission to AIM

  • Premaitha's Admission and trading of its Ordinary Shares on AIM commences at 08.00hrs today (TIDM: NIPT).

  • The Company has raised £7.2 million by way of a Placing and Open Offer at a price of 11 pence per share.

  • The proceeds of the Placing and Open Offer will be used to commercialise the IONA® test and provide capital for the Enlarged Group's sales and marketing initiatives.

  • The issued share capital of the Company on Admission comprises 188,163,709 ordinary shares of 10 pence each.

Click on, or paste the following link into your web browser, to view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/4400L_1-2014-7-4.pdf

This information is provided by RNS
The company news service from the London Stock Exchange

Contact Information:

Enquiries:

Premaitha Health plc
David Evans
Chairman (Non-Executive)
Dr Stephen Little
Chief Executive Officer
Joanne Cross
Marketing Communications
Tel: +44 (0) 7736 843052
Email: investors@premaitha.com

Cairn Financial Advisers LLP
Nomad
Liam Murray
Avi Robinson
Tel: +44 20 7148 7900

Panmure Gordon (UK) Limited
Broker
Robert Naylor
Freddy Crossley
Tel: +44 20 7886 2500

TooleyStreet Communications
Investor and media relations
Fiona Tooley
Tel: +44 (0) 7785 703523
fiona@tooleystreet.com

Instinctif Partners
Corporate and commercial communications
Sue Charles
Jen Lewis
Emma Barlow
Tel: +44 (0) 1260 296 500
premaitha@instinctif.com